Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer. 



Therapeutics

Biotechnology

Pheast Therapeutics

Pheast Therapeutics' headquarters in Palo Alto, CA, United States

Amira Barkal

Andrew Ferguson

Ivy Nguyen

Susan L.

Sarah Fernandes

Suzana Kahn

Thomas Marty

Moriah Katherine Nachbaur

Jennifer Yinuo Cao

Tiffany van Londen

The Research and Development team at Pheast Therapeutics is dedicated to discovering and optimizing innovative checkpoint therapies that activate the innate immune system to combat cancer. This multidisciplinary team, comprising scientists and research associates, conducts cutting-edge research, designs and executes experimental studies, and analyzes data to advance therapeutic candidates through the development pipeline. Their collaborative efforts aim to translate scientific discoveries into effective treatments for cancer patients.

Research and Development

The Leadership Team at Pheast Therapeutics is responsible for setting the strategic direction of the company, driving innovative research initiatives, and overseeing the development of novel cancer immunotherapies. Comprising key founders and executives, the team collaborates to secure funding, guide scientific advancements, and ensure operational efficiency, ultimately aiming to bring effective treatments to market to combat cancer.

��

Pheast Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Offices

��������

Pheast Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Offices

Related companies

��